Literature DB >> 21593180

Molecular epidemiology and phylogeny reveal complex spatial dynamics in areas where canine parvovirus is endemic.

S R Clegg1, K P Coyne, J Parker, S Dawson, S A Godsall, G Pinchbeck, P J Cripps, R M Gaskell, A D Radford.   

Abstract

Canine parvovirus type 2 (CPV-2) is a severe enteric pathogen of dogs, causing high mortality in unvaccinated dogs. After emerging, CPV-2 spread rapidly worldwide. However, there is now some evidence to suggest that international transmission appears to be more restricted. In order to investigate the transmission and evolution of CPV-2 both nationally and in relation to the global situation, we have used a long-range PCR to amplify and sequence the full VP2 gene of 150 canine parvoviruses obtained from a large cross-sectional sample of dogs presenting with severe diarrhea to veterinarians in the United Kingdom, over a 2-year period. Among these 150 strains, 50 different DNA sequence types (S) were identified, and apart from one case, all appeared unique to the United Kingdom. Phylogenetic analysis provided clear evidence for spatial clustering at the international level and for the first time also at the national level, with the geographical range of some sequence types appearing to be highly restricted within the United Kingdom. Evolution of the VP2 gene in this data set was associated with a lack of positive selection. In addition, the majority of predicted amino acid sequences were identical to those found elsewhere in the world, suggesting that CPV VP2 has evolved a highly fit conformation. Based on typing systems using key amino acid mutations, 43% of viruses were CPV-2a, and 57% CPV-2b, with no type 2 or 2c found. However, phylogenetic analysis suggested complex antigenic evolution of this virus, with both type 2a and 2b viruses appearing polyphyletic. As such, typing based on specific amino acid mutations may not reflect the true epidemiology of this virus. The geographical restriction that we observed both within the United Kingdom and between the United Kingdom and other countries, together with the lack of CPV-2c in this population, strongly suggests the spread of CPV within its population may be heterogeneously subject to limiting factors. This cross-sectional study of national and global CPV phylogeographic segregation reveals a substantially more complex epidemic structure than previously described.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593180      PMCID: PMC3147911          DOI: 10.1128/JVI.01576-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.

Authors:  Stéphane Guindon; Olivier Gascuel
Journal:  Syst Biol       Date:  2003-10       Impact factor: 15.683

Review 2.  Parvovirus replication.

Authors:  K I Berns
Journal:  Microbiol Rev       Date:  1990-09

3.  Nucleotide sequence and genome organization of canine parvovirus.

Authors:  A P Reed; E V Jones; T J Miller
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

4.  Datamonkey: rapid detection of selective pressure on individual sites of codon alignments.

Authors:  Sergei L Kosakovsky Pond; Simon D W Frost
Journal:  Bioinformatics       Date:  2005-02-15       Impact factor: 6.937

5.  An enteric disease of dogs reselmbing feline panleucopaenia.

Authors:  W R Kelly
Journal:  Aust Vet J       Date:  1978-12       Impact factor: 1.281

6.  Evidence for evolution of canine parvovirus type 2 in Italy.

Authors:  Canio Buonavoglia; Vito Martella; Annamaria Pratelli; Maria Tempesta; Alessandra Cavalli; Domenico Buonavoglia; Giancarlo Bozzo; Gabriella Elia; Nicola Decaro; Leland Carmichael
Journal:  J Gen Virol       Date:  2001-12       Impact factor: 3.891

7.  Characterization of a nonhemagglutinating mutant of canine parvovirus.

Authors:  C R Parrish; G Burtonboy; L E Carmichael
Journal:  Virology       Date:  1988-03       Impact factor: 3.616

8.  Molecular characterization of canine parvovirus in Brazil by polymerase chain reaction assay.

Authors:  C A Pereira; T A Monezi; D U Mehnert; M D'Angelo; E L Durigon
Journal:  Vet Microbiol       Date:  2000-07-31       Impact factor: 3.293

9.  Characterization and recombination mapping of an antigenic and host range mutation of canine parvovirus.

Authors:  C R Parrish; L E Carmichael
Journal:  Virology       Date:  1986-01-15       Impact factor: 3.616

10.  Isolation and immunisation studies of a canine parco-like virus from dogs with haemorrhagic enteritis.

Authors:  M J Appel; F W Scott; L E Carmichael
Journal:  Vet Rec       Date:  1979-08-25       Impact factor: 2.695

View more
  13 in total

1.  Canine parvovirus type 2c identified from an outbreak of severe gastroenteritis in a litter in Sweden.

Authors:  David Sutton; Carina Vinberg; Agneta Gustafsson; Jacqueline Pearce; Neil Greenwood
Journal:  Acta Vet Scand       Date:  2013-09-10       Impact factor: 1.695

2.  Phylogenetic and genome-wide deep-sequencing analyses of canine parvovirus reveal co-infection with field variants and emergence of a recent recombinant strain.

Authors:  Ruben Pérez; Lucía Calleros; Ana Marandino; Nicolás Sarute; Gregorio Iraola; Sofia Grecco; Hervé Blanc; Marco Vignuzzi; Ofer Isakov; Noam Shomron; Lucía Carrau; Martín Hernández; Lourdes Francia; Katia Sosa; Gonzalo Tomás; Yanina Panzera
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

3.  Inter- and intracontinental migrations and local differentiation have shaped the contemporary epidemiological landscape of canine parvovirus in South America.

Authors:  Sofía Grecco; Gregorio Iraola; Nicola Decaro; Alice Alfieri; Amauri Alfieri; Marina Gallo Calderón; Ana Paula da Silva; Daniela Name; Jaime Aldaz; Lucía Calleros; Ana Marandino; Gonzalo Tomás; Leticia Maya; Lourdes Francia; Yanina Panzera; Ruben Pérez
Journal:  Virus Evol       Date:  2018-04-09

4.  New approaches to pharmacosurveillance for monitoring prescription frequency, diversity, and co-prescription in a large sentinel network of companion animal veterinary practices in the United Kingdom, 2014-2016.

Authors:  D A Singleton; F Sánchez-Vizcaíno; E Arsevska; S Dawson; P H Jones; P J M Noble; G L Pinchbeck; N J Williams; A D Radford
Journal:  Prev Vet Med       Date:  2018-09-08       Impact factor: 2.670

5.  Pharmaceutical Prescription in Canine Acute Diarrhoea: A Longitudinal Electronic Health Record Analysis of First Opinion Veterinary Practices.

Authors:  David A Singleton; P J M Noble; Fernando Sánchez-Vizcaíno; Susan Dawson; Gina L Pinchbeck; Nicola J Williams; Alan D Radford; Philip H Jones
Journal:  Front Vet Sci       Date:  2019-07-02

6.  Molecular epidemiology of canine parvovirus type 2 in Italy from 1994 to 2017: recurrence of the CPV-2b variant.

Authors:  Mara Battilani; Francesco Modugno; Francesco Mira; Giuseppa Purpari; Santina Di Bella; Annalisa Guercio; Andrea Balboni
Journal:  BMC Vet Res       Date:  2019-11-04       Impact factor: 2.741

7.  Evidence for natural recombination between mink enteritis virus and canine parvovirus.

Authors:  Jianke Wang; Shipeng Cheng; Li Yi; Yuening Cheng; Shen Yang; Hongli Xu; Hang Zhao; Xijun Yan; Hua Wu
Journal:  Virol J       Date:  2012-10-30       Impact factor: 4.099

8.  Identification of canine parvovirus with the Q370R point mutation in the VP2 gene from a giant panda (Ailuropoda melanoleuca).

Authors:  Ling Guo; Shao-lin Yang; Shi-jie Chen; Zhihe Zhang; Chengdong Wang; Rong Hou; Yupeng Ren; Xintian Wen; Sanjie Cao; Wanzhu Guo; Zhongxiang Hao; Zifang Quan; Manli Zhang; Qi-gui Yan
Journal:  Virol J       Date:  2013-05-26       Impact factor: 4.099

9.  Isolation of Canine parvovirus with a view to identify the prevalent serotype on the basis of partial sequence analysis.

Authors:  Gurpreet Kaur; Mudit Chandra; P N Dwivedi; N S Sharma
Journal:  Vet World       Date:  2015-01-13

10.  Investigation of a Canine Parvovirus Outbreak using Next Generation Sequencing.

Authors:  Jayme Parker; Molly Murphy; Karsten Hueffer; Jack Chen
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.